Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yenan Mo"'
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Bupi Yishen Formula (BYF), a patent traditional Chinese medicine (TCM) formulation, has been used in the clinical treatment of chronic kidney disease (CKD). However, the mechanism of action of BYF has not been fully elucidated. Me
Externí odkaz:
https://doaj.org/article/91fb57aa643b41388436d69af2b2d677
Autor:
Zhiren He, Haijing Hou, Difei Zhang, Yenan Mo, La Zhang, Guobin Su, Junjie Lin, Liming Lu, Jingyao Huang, Yewen Gu, Ying Zhang, Jingxia Lin, Fengling Yuan, Yu Peng, Hui Liang, Daixin Zhao, Fuhua Lu, Xusheng Liu, Lixin Wang
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-11 (2020)
Abstract Background The optimal choice of treatment, with hemodialysis (HD) or peritoneal dialysis (PD), for end-stage renal disease (ESRD) patients, is still controversial. Only a few studies comparing HD and PD have been conducted in China, which h
Externí odkaz:
https://doaj.org/article/3d8a38dfa26148c8970089fb8d4678e1
Autor:
Chunlan Ji, Yin Li, Yenan Mo, Zhaoyu Lu, Fuhua Lu, Qizhan Lin, Xusheng Liu, Chuan Zou, Yuchi Wu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objectives: Trimethylamine N-oxide (TMAO), a metabolic product of gut flora, is increased in chronic kidney disease (CKD) subjects and is recognized as one type of uremic toxins which is associated with poor cardiovascular outcomes and kidney functio
Externí odkaz:
https://doaj.org/article/ff84a8e94bf24e1aa1b176f84dbb0613
Autor:
Yenan Mo, Huang Sun, Lei Zhang, Wenjia Geng, Lixin Wang, Chuan Zou, Yuchi Wu, Chunlan Ji, Xusheng Liu, Zhaoyu Lu
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objectives: As nitrogen-free precursors of corresponding essential amino, α-ketoacid have been widely prescribed to end-stage renal disease patients together with a low protein diet However, the impact of α-ketoacid on intestinal microbiota in chro
Externí odkaz:
https://doaj.org/article/7750d45eac744a7c9b50acde3638f2b7
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that promotes cell responses to small molecules derived from the diet, microorganisms, metabolism and pollutants. The AhR signal regulates many basic cellular processes, i
Externí odkaz:
https://doaj.org/article/f38088f540e44bbb8caa3f570530c25c
Publikováno v:
Journal of Ethnopharmacology. 308:116244
Publikováno v:
BMC Complementary Medicine and Therapies
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-14 (2021)
BMC Complementary Medicine and Therapies, Vol 21, Iss 1, Pp 1-14 (2021)
Background Bupi Yishen Formula (BYF), a patent traditional Chinese medicine (TCM) formulation, has been used in the clinical treatment of chronic kidney disease (CKD). However, the mechanism of action of BYF has not been fully elucidated. Method To i
Autor:
Cuixia Xiao, La Zhang, David W. Johnson, Lixin Wang, Jiahao Zeng, Guobin Su, Xusheng Liu, Cecilia Stålsby Lundborg, Yenan Mo, Dorothea Nitsch, Fuhua Lu
Publikováno v:
Vaccine. 38(47)
Background A lower conversion vaccination rate and a more rapid decline in antibody titers over time in dialysis patients raise concerns about the effectiveness of pneumococcal vaccination (PV) in this population, which has not been systematically re
Autor:
Zhiren He, Difei Zhang, Yenan Mo, La Zhang, Junjie Lin, LiMing Lu, Guobin Su, Jingrao Huang, Yewen Gu, Ying Zhang, Jingxia Lin, Fengling Yuan, Yu Peng, Hui Liang, Daixing Zhao, Fuhua Lu, Xusheng Liu, Haijing Hou, Lixing Wang
Background Up to date, whether hemodialysis (HD) or peritoneal dialysis (PD) is a better choice for end-stage renal disease (ESRD) patients has been debatable. Few study comparing HD and PD was from China, a large country with the largest number of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f2faee88c3da9fada6aeaabfb0ec28e
https://doi.org/10.21203/rs.3.rs-20276/v1
https://doi.org/10.21203/rs.3.rs-20276/v1
Autor:
Youqing Cai, Huang Jing, Zhiren He, Xusheng Liu, Qinqing Hu, Xindong Qin, Junjie Lin, Zhuangzhu Liu, Yenan Mo, Lixin Wang
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2014 (2014)
Evidence-Based Complementary and Alternative Medicine, Vol 2014 (2014)
Objective. To evaluate the effectiveness and safety of Shenfu injection (SFI) for intradialytic hypotension (IDH).Methods. A systematic review of data sources published as of April 2014 was conducted. These included the Cochrane Central Register of C